Clinical trial report: treatment of cryptococcal meningitis in the developing world

Affiliations

Allan R Tunkel. Curr Infect Dis Rep. 2010 Jul.

. 2010 Jul;12(4):234-6.

doi: 10.1007/s11908-010-0107-2.

¹ Department of Medicine, Monmouth Medical Center, 300 Second Avenue, Room G417, Long Branch, NJ, 07740, USA, atunkel@sbhcs.com.

No abstract available

Similar articles

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Park BJ, et al. AIDS. 2009 Feb 20;23(4):525-30. doi: 10.1097/QAD.0b013e328322ffac. AIDS. 2009. PMID: 19182676 Review.
Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
Maher D, Mwandumba H. Maher D, et al. J Infect. 1994 Jan;28(1):59-64. doi: 10.1016/s0163-4453(94)94161-0. J Infect. 1994. PMID: 8163834
Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?
Jhamb R, Kashyap B, Das S, Berry N, Garg A. Jhamb R, et al. Int J STD AIDS. 2014 Apr;25(5):369-72. doi: 10.1177/0956462413506889. Epub 2013 Oct 9. Int J STD AIDS. 2014. PMID: 24108453
The spectrum of meningitis in a population with high prevalence of HIV disease.
Bergemann A, Karstaedt AS. Bergemann A, et al. QJM. 1996 Jul;89(7):499-504. doi: 10.1093/qjmed/89.7.499. QJM. 1996. PMID: 8759489
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.
Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS. Williamson PR, et al. Nat Rev Neurol. 2017 Jan;13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016 Nov 25. Nat Rev Neurol. 2017. PMID: 27886201 Review.